Literature DB >> 30619674

Vertebral Osteomyelitis: A Comparison of Associated Outcomes in Early Versus Delayed Surgical Treatment.

Frank A Segreto1, George A Beyer2, Preston Grieco3, Samantha R Horn1, Cole A Bortz1, Cyrus M Jalai1, Peter G Passias1, Carl B Paulino3, Bassel G Diebo3.   

Abstract

BACKGROUND: The recommended timing of surgical intervention for vertebral osteomyelitis (VO) is controversial; however, most studies are not sufficiently powered. Our goal was to investigate the associated effects of delaying surgery in VO patients on in-hospital complications, neurologic deficits, and mortality.
METHODS: Retrospective review of the National Inpatient Sample. Patients who underwent surgery for VO from 1998 to 2013 were identified using codes from the International Classification of Disease, Ninth Revision, Clinical Modification. Patients were stratified into groups based on incremental delay of surgery: 0-day delay (same-day surgery), 1-day delay, 2-day delay, 3- to 6-day delay, 7- to 14-day delay, and 14- to 30-day delay. Univariate analysis compared demographics and outcomes between groups. Multivariate logistic regression models calculated independent predictors of any complication, mortality, and neurologic deficits. A 0-day delay was the reference group.
RESULTS: A total of 34 465 patients were identified. Delayed groups were older (same day: 53.5 vs. 7-14-day delay: 61.1) and had a higher Deyo-Charlson score (same day: 0.4901 vs. 14-30-day delay: 1.66), length of stay (same day: 4.2 vs. 14-30-day delay: 34.04 days), and total charges (same day: $63,390.78 vs. 14-30-day delay: $245,752.4), all P < .001. Delayed groups had higher surgical combined-approach rates (same day: 9.1% vs. 14-30-day delay: 31.5%) and lower anterior-approach rates (same day: 42.4% vs. 14-30-day delay: 24.2%). Delayed groups had increased mortality and complication rates. Regressions showed delayed groups as the strongest independent indicators of any complication (14-30-day delay: odds ratio [OR] 3.384), mortality (14-30-day delay: OR 10.658), and neurologic deficits (14-30-day delay: OR 3.464), all P < .001.
CONCLUSION: VO patients who operate within 24 hours of admission are more likely to have desirable outcomes. Patients with delayed surgery had a significantly increased risk of developing any complication, mortality, and discharging with neurologic deficits. LEVEL OF EVIDENCE: III. CLINICAL RELEVANCE: Medically fit patients may benefit from earlier surgical management in order to reduce risk of postoperative complications, improve outcomes, and reduce overall hospital costs.

Entities:  

Keywords:  spinal fusion; spondylodiscitis; surgical delay; vertebral osteomyelitis

Year:  2018        PMID: 30619674      PMCID: PMC6314341          DOI: 10.14444/5088

Source DB:  PubMed          Journal:  Int J Spine Surg        ISSN: 2211-4599


  37 in total

1.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

Review 2.  Vertebral osteomyelitis.

Authors:  Jorge J Jaramillo-de la Torre; Robert J Bohinski; Charles Kuntz
Journal:  Neurosurg Clin N Am       Date:  2006-07       Impact factor: 2.509

Review 3.  Spinal epidural abscess.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

4.  Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals.

Authors:  Martin C McHenry; Kirk A Easley; Geri A Locker
Journal:  Clin Infect Dis       Date:  2002-04-22       Impact factor: 9.079

5.  Disparities in cancer diagnosis and survival.

Authors:  C J Bradley; C W Given; C Roberts
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

6.  Development of a comorbidity index using physician claims data.

Authors:  C N Klabunde; A L Potosky; J M Legler; J L Warren
Journal:  J Clin Epidemiol       Date:  2000-12       Impact factor: 6.437

7.  Better treatment of vertebral osteomyelitis using posterior stabilization and titanium mesh cages.

Authors:  Hwan T Hee; Mohammad E Majd; Richard T Holt; David Pienkowski
Journal:  J Spinal Disord Tech       Date:  2002-04

8.  Osteomyelitis of the cervical spine: a potentially dramatic disease.

Authors:  Ralph C Schimmer; Christina Jeanneret; Pierce D Nunley; Bernard Jeanneret
Journal:  J Spinal Disord Tech       Date:  2002-04

9.  Effects of health insurance and race on colorectal cancer treatments and outcomes.

Authors:  R G Roetzheim; N Pal; E C Gonzalez; J M Ferrante; D J Van Durme; J P Krischer
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

10.  Cancer survival in Kentucky and health insurance coverage.

Authors:  Kathleen McDavid; Thomas C Tucker; Andrew Sloggett; Michel P Coleman
Journal:  Arch Intern Med       Date:  2003-10-13
View more
  5 in total

Review 1.  Pyogenic spondylodiscitis : The quest towards a clinical-radiological classification.

Authors:  H Almansour; W Pepke; M Akbar
Journal:  Orthopade       Date:  2020-06       Impact factor: 1.087

2.  Vertebral Osteomyelitis: A Mortality Analysis Comparing Surgical and Conservative Management.

Authors:  Spogmai Zadran; Peter Heide Pedersen; Søren Eiskjær
Journal:  Global Spine J       Date:  2019-07-10

3.  First-4-week erythrocyte sedimentation rate variability predicts erythrocyte sedimentation rate trajectories and clinical course among patients with pyogenic vertebral osteomyelitis.

Authors:  Hsiu-Yin Chiang; Chih-Wei Chung; Chin-Chi Kuo; Yen-Chun Lo; Wei-Shuo Chang; Chih-Yu Chi
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.752

4.  Early surgery may lower mortality in patients suffering from severe spinal infection.

Authors:  Sara Lener; Christoph Wipplinger; Anna Stocsits; Sebastian Hartmann; Anja Hofer; Claudius Thomé
Journal:  Acta Neurochir (Wien)       Date:  2020-07-29       Impact factor: 2.216

Review 5.  Recent advances in the local antibiotics delivery systems for management of osteomyelitis.

Authors:  Reem Khaled Wassif; Maha Elkayal; Rehab Nabil Shamma; Seham A Elkheshen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.